Johnson & Johnson in talks to buy Crucell
September 17, 2010 at 04:59 AM EDT
U.S. drug giant Johnson & Johnson is in talks to buy all shares of Dutch biopharmaceutical firm Crucell that it doesn’t already own.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.